All new medicines introduced into the market are the result of lengthy, costly and risky research and development conducted by pharmaceutical companies:
Average time for a medicinal product to reach the market, since the first synthesis of the new active substance.
The estimated cost of researching and developing a new chemical or biological entity in 2012.
($1506 million in 2011)
(Mestre-ferrandiz et al, office of Health Economics, December 2012)
Average substances in laboratories that will successfully pass all stages of development required to become a marketable medicine
Data source: Eurostat, data relate to year 2010 (non-disease directly related causes of deaths: EFPIA calculations – percentages do not add due to rounding), April 2014